A Pilot Phase IIB, Randomized, Multi-Center Trial of Agratroban in Combination with Recombinant Tissue Plasminogen Activator for Acute Stroke (ARTSS-2)

Grant

Date/time Interval

  • March 1, 2013 - February 28, 2014

    • Awarded By

    Total Award Amount

  • 31794.00

    • Direct Costs

  • 21702.00

    • Sponsor Award Id

    • Contributor

  • Michael Lyerly   Investigator